Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient of Anemia in Chronic Renal Failure With Hemodialysis”

59 trials

Showing 20 of 59 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07162090
What this trial is testing

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

Who this might be right for
SarcopeniaAnemia Associated With Chronic Kidney Disease (CKD)Dialysis Patients
Tianjin Medical University General Hospital 60
Large-scale testing (Phase 3)Study completedNCT01473407
What this trial is testing

Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Who this might be right for
Chronic Kidney DiseaseChronic Renal Failure
Pfizer 612
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Large-scale testing (Phase 3)Study completedNCT02952092
What this trial is testing

Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia

Who this might be right for
Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc 303
Testing effectiveness (Phase 2)Study completedNCT01630889
What this trial is testing

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal DiseaseAnemia
Kyntra Bio 15
Not applicableStudy completedNCT01940484
What this trial is testing

An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis

Who this might be right for
Anemia
Hoffmann-La Roche 98
Large-scale testing (Phase 3)Study completedNCT04410198
What this trial is testing

Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants

Who this might be right for
Anemia Associated With End Stage Renal Disease (ESRD)
Kyntra Bio 203
Large-scale testing (Phase 3)Study completedNCT02779764
What this trial is testing

A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment

Who this might be right for
Hemodialysis Patients With Renal Anemia
Astellas Pharma Inc 164
Large-scale testing (Phase 3)Study completedNCT02273726
What this trial is testing

Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis

Who this might be right for
CKD Anemia in Stable Dialysis Patients
Kyntra Bio 741
Not applicableStudy completedNCT01667380
What this trial is testing

An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)

Who this might be right for
Anemia
Hoffmann-La Roche 78
Large-scale testing (Phase 3)Ended earlyNCT00450333
What this trial is testing

Dynepo Infrequent Dosing Study

Who this might be right for
AnemiaKidney Failure
Shire 407
Not applicableStudy completedNCT01049711
What this trial is testing

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients

Who this might be right for
Chronic Renal Failure
Mahidol University 152
Large-scale testing (Phase 3)Study completedNCT00717821
What this trial is testing

Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.

Who this might be right for
Anemia
Hoffmann-La Roche 421
Large-scale testing (Phase 3)Study completedNCT01473420
What this trial is testing

Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Who this might be right for
Chronic Renal FailureChronic Kidney Disease
Pfizer 320
Post-approval studies (Phase 4)Study completedNCT02817555
What this trial is testing

Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients

Who this might be right for
AnemiaChronic Kidney Disease
Andrea L Woodland 50
Large-scale testing (Phase 3)Study completedNCT04027517
What this trial is testing

Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.

Who this might be right for
Anemia of Chronic Kidney Disease
JW Pharmaceutical 172
Large-scale testing (Phase 3)Study completedNCT04484857
What this trial is testing

Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants

Who this might be right for
Anemia Associated With End Stage Renal Disease
Kyntra Bio 283
Large-scale testing (Phase 3)Study completedNCT00261521
What this trial is testing

The Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients

Who this might be right for
Kidney Failure, ChronicAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 596
Not applicableLooking for participantsNCT04330729
What this trial is testing

The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp

Who this might be right for
Erythropoietin Adverse Reaction
Zealand University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02044653
What this trial is testing

Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

Who this might be right for
AnemiaChronic Kidney Disease
Genexine, Inc. 257
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation